Obliteride Impact

Philanthropic support from Obliteriders and other generous donors provides crucial funding for transformative discovery at Fred Hutch.

“This passionate community makes a profound impact,” said Kelly O’Brien, vice president of philanthropy. “We are honored by their partnership and commitment. Obliteride’s support helps us accelerate the pace and scale of research, hire and retain top scientists, and continue to shorten the distance from the lab to the clinic.”

O’Brien pointed out that Obliteride’s fundraising also supports early-stage research, potentially unlocking millions in federal and foundation funding once projects get off the ground.

Many Obliteride participants share a personal commitment to helping Fred Hutch accelerate the pace and scale of research. Obliteride gives them the opportunity to raise funds for an area of ​​work at Fred Hutch that is most meaningful to them, including a specific disease area, program, researcher or clinician. Funds raised by the 2024 season of Obliteride will fuel research for 27 disease areas, 86 faculty members, and 25 programs and specialty areas at Fred Hutch.